GLP-1 (glucagon-like peptide-1) receptor agonist medications are a class of drugs used to treat diabetes and promote weight loss
(Oh, how we all wish that the fat would just disappear from certain areas of our choice!) The face relies on a series of discrete fat compartments layered over bone and beneath muscle and skin
Never stop taking Mounjaro without consulting your healthcare provider, as abrupt discontinuation may affect your glycaemic control or weight management progress
Because nutrients skip the gut, they reach circulation immediately and at higher concentrations than oral dosing allows
Here we compare the published data from the STEP-1, SURMOUNT-1, and TRIUMPH-4 trials without marketing spin: -14,9% for semaglutide, -20,9% for the tirzepatide-28,7% for the retatrutideThe retatrutide vs tirzepatide vs semaglutide comparison also incorporates tolerance (dysesthesia 20,9% at the 12 mg dose level of retatrutide), pleiotropic effects 2024-2025 (apnea, heart failure, MASLD), and the updated regulatory status in France 2026
The remaining authors have no disclosures
